Cargando…

Real-world outcomes in thoracic cancer patients with severe Acute respiratory syndrome Coronavirus 2 (COVID-19): Single UK institution experience

BACKGROUND: UK COVID-19 mortality rates are amongst the highest globally. Controversy exists on the vulnerability of thoracic cancer patients. We describe the characteristics and sequelae of patients with thoracic cancer treated at a UK cancer centre infected with COVID-19. METHODS: Patients undergo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Wanyuan, Yousaf, Nadia, Bhosle, Jaishree, Minchom, Anna, Nicholson, Andrew G., Ahmed, Merina, McDonald, Fiona, Locke, Imogen, Lee, Richard, O'Brien, Mary, Popat, Sanjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709731/ https://www.ncbi.nlm.nih.gov/pubmed/33310368 http://dx.doi.org/10.1016/j.ctarc.2020.100261

Ejemplares similares

1748P Real-world outcomes in thoracic cancer patients (pts) with severe acute respiratory syndrome coronavirus 2 (COVID-19): Single UK institution experience
por: Cui, W., et al.
Publicado: (2020)

Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource Implications
por: Hindocha, Sumeet, et al.
Publicado: (2021)

Safety monitoring of two and four-weekly adjuvant durvalumab for patients with stage III NSCLC: implications for the COVID-19 pandemic and beyond
por: Joshi, Kroopa, et al.
Publicado: (2021)

A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma
por: Minchom, Anna, et al.
Publicado: (2019)

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19
por: Cui, W., et al.
Publicado: (2021)

A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments
por: Minchom, Anna, et al.
Publicado: (2017)

HER3 expression and MEK activation in non-small-cell lung carcinoma
por: Manickavasagar, Thubeena, et al.
Publicado: (2021)

A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice
por: Linch, Mark, et al.
Publicado: (2014)

Epidermal Growth Factor Mutation as a Diagnostic and Therapeutic Target in Metastatic Poorly Differentiated Thyroid Carcinoma: A Case Report and Review of the Literature
por: Lote, Hazel, et al.
Publicado: (2014)

Splenic volume as a predictor of treatment response in patients with non-small cell lung cancer receiving immunotherapy
por: Castagnoli, Francesca, et al.
Publicado: (2022)

An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B(12) and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity
por: Minchom, A R, et al.
Publicado: (2014)

Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice
por: Abdelraouf, Fatma, et al.
Publicado: (2015)

Crizotinib-Resistant ROS1 G2101A Mutation Associated With Sensitivity to Lorlatinib in ROS1-Rearranged NSCLC: Case Report
por: Begum, Parvin, et al.
Publicado: (2022)

1241P Safety monitoring of adjuvant 2 weekly durvalumab for patients with stage III NSCLC: Implications for a 4 weekly regimen during the COVID-19 pandemic and beyond
por: Joshi, K., et al.
Publicado: (2020)

Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach
por: Pender, Alexandra, et al.
Publicado: (2015)

Early Response to Chemotherapy in Malignant Pleural Mesothelioma Evaluated Using Diffusion-Weighted Magnetic Resonance Imaging: Initial Observations
por: Curcean, Sebastian, et al.
Publicado: (2021)

Durable response of multiple myeloma and non‐small cell lung cancer with simultaneous, biologically targeted treatment
por: Kaiser, Martin F., et al.
Publicado: (2020)

Thoracic surgery in the UK
por: Pons, Aina, et al.
Publicado: (2022)

Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence–Enabled Studies of Acute Phosphoproteomic Changes
por: Coker, Elizabeth A., et al.
Publicado: (2022)

Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
por: Collins, Dearbhaile Catherine, et al.
Publicado: (2020)

Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
por: Collins, Dearbhaile Catherine, et al.
Publicado: (2021)

A review of injury epidemiology in the UK and Europe: some methodological considerations in constructing rates
por: Alexandrescu, Roxana, et al.
Publicado: (2009)

A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors
por: O’Brien, Mary E. R., et al.
Publicado: (2018)

A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models
por: Hindocha, Sumeet, et al.
Publicado: (2022)

A Comparison of Immunohistochemical Assays and FISH in Detecting the ALK Translocation in Diagnostic Histological and Cytological Lung Tumor Material
por: Le Quesne, John, et al.
Publicado: (2014)

Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists
por: Lindsay, Colin R., et al.
Publicado: (2021)

Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme
por: Lindsay, Colin R, et al.
Publicado: (2018)

What Level Should Preoperative Albumin of Thoracic and Lumbar Tuberculosis Patients Be Reached: A Case-Controlled Study
por: Jiang, Guanyin, et al.
Publicado: (2022)

A qualitative exploration of the impact of COVID-19 on individuals with eating disorders in the UK
por: Brown, SiennaMarisa, et al.
Publicado: (2021)

NATO Advanced Study Institute on Advanced Physical Oceanographic Numerical Modelling
por: O’Brien, James
Publicado: (1986)

Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC
por: Hindocha, Sumeet, et al.
Publicado: (2022)

Author Correction: Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC
por: Hindocha, Sumeet, et al.
Publicado: (2022)

Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer
por: Angelis, Vasileios, et al.
Publicado: (2020)

Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma
por: Gennatas, Spyridon, et al.
Publicado: (2013)

UK guidelines for managing long-term effects of COVID-19
por: Shah, Waqaar, et al.
Publicado: (2021)

Coronavirus Disease 2019: the Pivotal Role of UK Clinical Oncology and the UK Coronavirus Cancer Monitoring Project
por: Best, J., et al.
Publicado: (2021)

An introduction to the UK care pathway for children born with a cleft of the lip and/or palate
por: Dudding, Tom, et al.
Publicado: (2023)

The politics of technology assessment: institutions, processes, and policy disputes
por: Marchand, Donald A, et al.
Publicado: (1982)

The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world
por: Sharpe, Hannah R., et al.
Publicado: (2020)

An 8-month longitudinal exploration of body image and disordered eating in the UK during the COVID-19 pandemic
por: Sharpe, Helen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lqbiv5k6cgrnsnfaogps9nli7p